About FibroHeal
FibroHeal is a company based in Bengaluru (India) founded in 2017 by Subramanian Shivaraman, Vivek Mishra, and Bharat Tandon. FibroHeal has raised $3.8 million across 9 funding rounds from investors including C-CAMP, Startup Karnataka and KITVEN. The company has 29 employees as of April 08, 2024. FibroHeal offers products and services including D-Fibroheal Scarlite, D-Fibroheal Ag Particle, D-Fibroheal Particle, Fibrovid, and FibroZyme. FibroHeal operates in a competitive market with competitors including Serigen, KLISBio, Silk Biomed and OSPT, among others.
- Headquarter Bengaluru, India
- Employees 29 as on 08 Apr, 2024
- Founders Subramanian Shivaraman, Vivek Mishra, Bharat Tandon
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Fibroheal Woundcare Private Limited
- Date of Incorporation 06 Apr, 2017
- Jurisdiction Doddaballapura, Karnataka, India
-
Annual Revenue
$277.1 K (USD)195.05as on Mar 31, 2023
-
Net Profit
-$156.88 K (USD)30.48as on Mar 31, 2023
-
EBITDA
-$134.19 K (USD)43.6as on Mar 31, 2023
-
Total Equity Funding
$3.8 M (USD)
in 9 rounds
-
Latest Funding Round
$1.47 M (USD), Angel Round
Jul 08, 2026
-
Investors
C-CAMP
& 9 more
-
Employee Count
29
as on Apr 08, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of FibroHeal
FibroHeal offers a comprehensive portfolio of products and services, including D-Fibroheal Scarlite, D-Fibroheal Ag Particle, D-Fibroheal Particle, Fibrovid, and FibroZyme.
Product for effective scar management in wound healing.
Antimicrobial solution for controlling wound infections.
Material for general wound care and healing support.
Aid for viral or general skin wound treatment.
Enzyme-based product for tissue debridement in wounds.
Cream to maintain moisture in wound care routines.
Adhesive foam for protective wound coverage.
Foam with antimicrobial properties for wounds.
Adhesive antimicrobial foam for wound protection.
Gel to provide hydration for wound healing.
Spray for applying moisture to wounds.
General product for aiding wound recovery.
Meshed material for wound coverage and healing.
Polyurethane foam for non-adhesive wound protection.
Antimicrobial version for infection prevention.
Funding Insights of FibroHeal
FibroHeal has successfully raised a total of $3.8M across 9 strategic funding rounds. The most recent funding activity was a Angel Round of $1.47 million completed in July 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in FibroHeal
FibroHeal has secured backing from 10 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include C-CAMP, Startup Karnataka and KITVEN.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund backed by government financial institutions focused on early and growth stage startups
|
Locked | Locked | Locked | |
|
Venture capital is provided to biotech and health-tech startups.
|
Locked | Locked | Locked | |
|
Business incubation services are provided across multiple sectors.
|
Locked | Locked | Locked |
Investor details for FibroHeal
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by FibroHeal
Investment portfolio details for FibroHeal
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - FibroHeal
Detailed financials for FibroHeal
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fibroheal Comparisons
Peer comparison for FibroHeal
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of FibroHeal
FibroHeal operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Serigen, KLISBio, Silk Biomed and OSPT, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of protein-based tissue regeneration products for orthopedics
|
|
| Locked | Locked | Locked |
Developer of regenerative implantable products by using silk fibroins
|
|
| Locked | Locked | Locked |
Silk-based biomaterials are developed for therapeutic medical applications.
|
|
| Locked | Locked | Locked |
Pioneering antibacterial textiles to combat surgical implant and wound infections.
|
Detailed competitors of FibroHeal
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fibroheal
Complete news archive for FibroHeal
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about FibroHeal
FibroHeal was founded in 2017 and raised its 1st funding round 1 year after it was founded.
FibroHeal is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Vivek Mishra is the current CEO of FibroHeal. They have also founded this company.
FibroHeal is a funded company, having raised a total of $3.8M across 9 funding rounds to date.
As of Apr 08, 2024, the latest employee count at FibroHeal is 29.
Annual revenue of FibroHeal is $277.1K as on Mar 31, 2023.
Developer of silk proteins as biomaterials for wound healing. The company is leveraging the biomaterial application of silk proteins to develop the most innovative advance and active wound care products to heal acute and chronic wounds. The company is working exclusively on healing different types of acute and chronic wounds and has a comprehensive product range addressing different stages of wounds.
FibroHeal's top competitors include Serigen, KLISBio and Silk Biomed.
FibroHeal offers D-Fibroheal Scarlite, D-Fibroheal Ag Particle, D-Fibroheal Particle, Fibrovid, and 6 more products and services.
FibroHeal has 10 investors. Key investors include C-CAMP, Startup Karnataka, KITVEN, KK Narayanan, and Karnataka Trustee.
The valuation of FibroHeal is $7.05M as of Nov 2022.